Skip to content
lifestyle.cosmeticsurgeryinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Precigen, Inc
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
June 15, 2026
Precigen Reports ‘Robust Uptake’ of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
April 7, 2026